Need the life-sciences signal but short on time?
Get a free quarterly briefing: four pages on what life-sciences operators are actually saying about Biosecure, AI hype vs. substance, and the $50,000 cell-therapy question. Ten minutes, in your inbox.
Jesús Zurdo is a scientist — molecular biology, drug discovery, manufacturing, company creation. Three and a half years ago, he was diagnosed with Philadelphia-positive acute lymphoblastic leukemia. 92% of his bone marrow was cancer cells. His donor was a stranger in Florida.
In Today’s Episode We Discuss:
Get a free quarterly briefing: four pages on what life-sciences operators are actually saying about Biosecure, AI hype vs. substance, and the $50,000 cell-therapy question. Ten minutes, in your inbox.
Free briefing
Four pages, ten minutes: the Biosecure Act, AI hype vs. substance, and the $50,000 cell-therapy question. Drop your email and it is in your inbox.
No spam. Unsubscribe anytime.
Check your inbox.
Your briefing is on its way.
